Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort's QuAliV ancillary study.
Barger D, Hessamfar M, Neau D, Vareil MO, Lazaro E, Duffau P, Rouanes N, Leleux O, Le Marec F, Erramouspe M, Wittkop L, Dabis F, Bonnet F. Barger D, et al. Among authors: leleux o. Health Qual Life Outcomes. 2020 Jul 10;18(1):220. doi: 10.1186/s12955-020-01451-8. Health Qual Life Outcomes. 2020. PMID: 32650781 Free PMC article.
Statin use and risk of severe bacterial infection in a population living with HIV: prospective cohort study of the ANRS CO3 Aquitaine Cohort 2000-2018.
Teruel E, Vandenhende MA, Neau D, Lazaro E, Duffau P, Vareil MO, Cazanave C, Perrier A, le Marec F, Leleux O, Bonnet F, Wittkop L. Teruel E, et al. Among authors: leleux o. Clin Microbiol Infect. 2021 Sep;27(9):1301-1307. doi: 10.1016/j.cmi.2020.11.019. Epub 2020 Dec 1. Clin Microbiol Infect. 2021. PMID: 33276140 Free article.
Long-term follow-up of HIV-1 multi-drug-resistant treatment-experienced participants treated with etravirine, raltegravir and boosted darunavir: towards drug-reduced regimen? ANRS CO3 Aquitaine Cohort 2007-2018.
Nyamankolly E, Bellecave P, Wittkop L, Le Marec F, Duffau P, Lazaro E, Vareil MO, Tumiotto C, Hessamfar M, Cazanave C, Perrier A, Leleux O, Bonnet F, Neau D. Nyamankolly E, et al. Among authors: leleux o. Int J Antimicrob Agents. 2023 Jan;61(1):106696. doi: 10.1016/j.ijantimicag.2022.106696. Epub 2022 Dec 2. Int J Antimicrob Agents. 2023. PMID: 36470511
Tobacco, alcohol, cannabis, and illicit drug use and their association with CD4/CD8 cell count ratio in people with controlled HIV: a cross-sectional study (ANRS CO3 AQUIVIH-NA-QuAliV).
Devos S, Bonnet F, Hessamfar M, Neau D, Vareil MO, Leleux O, Cazanave C, Rouanes N, Duffau P, Lazaro E, Dabis F, Wittkop L, Barger D; ANRS CO3-AQUIVIH-NA-QuAliV. Devos S, et al. Among authors: leleux o. BMC Infect Dis. 2023 Jan 9;23(1):16. doi: 10.1186/s12879-022-07963-6. BMC Infect Dis. 2023. PMID: 36624391 Free PMC article.
Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study).
Ben Farhat J, Hessamfar M, Farbos S, Desclaux A, Dumondin G, Ferrand H, Greib C, Castan B, Rispal P, Duffau P, Leleux O, Perrier A, Wittkop L, Bonnet F, Barger D. Ben Farhat J, et al. Among authors: leleux o. J Acquir Immune Defic Syndr. 2024 Jan 1;95(1):1-5. doi: 10.1097/QAI.0000000000003310. J Acquir Immune Defic Syndr. 2024. PMID: 37757852
Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort.
Wittkop L, Breilh D, Da Silva D, Duffau P, Mercié P, Raymond I, Anies G, Fleury H, Saux MC, Dabis F, Fagard C, Thiébaut R, Masquelier B, Pellegrin I; ANRS CO3 Aquitaine Cohort. Wittkop L, et al. J Antimicrob Chemother. 2009 Jun;63(6):1251-5. doi: 10.1093/jac/dkp114. Epub 2009 Mar 31. J Antimicrob Chemother. 2009. PMID: 19336453 Free PMC article. Clinical Trial.
Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort.
Bruyand M, Thiébaut R, Lawson-Ayayi S, Joly P, Sasco AJ, Mercié P, Pellegrin JL, Neau D, Dabis F, Morlat P, Chêne G, Bonnet F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA). Bruyand M, et al. Clin Infect Dis. 2009 Oct 1;49(7):1109-16. doi: 10.1086/605594. Clin Infect Dis. 2009. PMID: 19705973 Free PMC article.
45 results